###begin article-title 0
Zinc-finger domains of the transcriptional repressor KLF15 bind multiple sites in rhodopsin and IRBP promoters including the CRS-1 and G-rich repressor elements
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 452 459 452 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Kr&#252;ppel</italic>
###xml 534 543 534 543 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 606 616 606 616 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rhodopsin </italic>
###xml 620 629 620 629 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IRBP/Rbp3</italic>
###xml 863 873 863 873 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rhodopsin </italic>
###xml 877 882 877 882 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IRBP </italic>
In the retina, many of the genes that encode components of the visual transduction cascade and retinoid recycling are exclusively expressed in photoreceptor cells and show highly stereotyped temporal and spatial expression patterns. Multiple transcriptional activators of photoreceptor-specific genes have been identified, but little is known about negative regulation of gene expression in the retina. We recently identified KLF15, a member of the Sp/Kruppel-like Factor family of zinc-finger containing transcription factors, as an in vitro repressor of the promoters of the photoreceptor-specific genes rhodopsin and IRBP/Rbp3. To gain further insight into the mechanism of KLF15-mediated regulation of gene expression, we have characterized the binding characteristics and specificity of KLF15's DNA binding domains and defined the KLF15 binding sites in the rhodopsin and IRBP promoters.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 256 266 256 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rhodopsin </italic>
###xml 270 275 270 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IRBP </italic>
###xml 484 494 484 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rhodopsin </italic>
###xml 249 255 <span type="species:ncbi:9913">bovine</span>
###xml 455 461 <span type="species:ncbi:9913">bovine</span>
###xml 463 468 <span type="species:ncbi:9606">human</span>
###xml 480 483 <span type="species:ncbi:9615">dog</span>
In EMSA and DNAseI footprinting assays, a KLF15-GST fusion protein containing the C-terminal zinc-finger domains (123 amino acids) showed zinc-dependent and sequence-specific binding to a 9 bp consensus sequence containing a core CG/TCCCC. Both the bovine rhodopsin and IRBP promoters contained multiple KLF15 binding sites that included the previously identified CRS-1 and G-rich repressor elements. KLF15 binding sites were highly conserved between the bovine, human, chimp and dog rhodopsin promoters, but less conserved in rodents. KLF15 reduced luciferase expression by bRho130-luc (containing 4 KLF15 sites) and repressed promoter activation by CRX (cone rod homeobox) and/or NRL (neural retina leucine zipper), although the magnitude of the reduction was smaller than previously reported for a longer bRho225-luc (containing 6 KFL15 sites).
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 52 62 52 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rhodospin </italic>
###xml 66 71 66 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IRBP </italic>
###xml 225 233 225 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
KLF15 binds to multiple 9 bp consensus sites in the Rhodospin and IRBP promoters including the CRS-1 and G-rich repressor elements. Based on the known expression pattern of KLF15 in non-photoreceptor cells, we hypothesize an in vivo role for KLF15 in repressing photoreceptor-specific gene expression in the inner retina.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 556 557 549 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 558 559 551 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 683 684 676 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 685 686 678 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 726 727 719 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 728 729 721 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 730 732 723 725 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
Photoreceptors are the highly specialized sensory receptors of the retina and express a unique array of genes that enable them to convert light energy into a neural signal. Many of these genes, including those encoding components of the phototransduction cascade [e.g. rhodopsin (Rho), transducin, arrestin, alpha- and beta-phosphodiesterase (PDE)] and those involved in retinoid recycling [e.g. interphotoreceptor retinoid binding protein (IRBP/RBP3)], are expressed only in photoreceptor cells in the retina and in a subset of cells in the pineal gland [1-5]. In addition, these genes have highly stereotyped temporal and spatial patterns of expression during retinal development [6-8] that are transcriptionally regulated [7,9,10]. We are interested in understanding the transcriptional networks that regulate photoreceptor-specific gene expression, not only as a model for cell-specific gene regulation, but to gain insight into the mechanisms that regulate photoreceptor differentiation and neuro-degenerative retinal disease.
###end p 9
###begin p 10
###xml 38 42 38 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rho </italic>
###xml 109 111 109 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 112 114 112 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 120 125 120 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IRBP </italic>
###xml 143 144 143 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 145 147 145 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 393 395 393 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 396 398 396 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 460 462 460 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 463 465 463 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 466 468 466 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 469 471 469 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 652 654 652 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 665 667 665 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 675 677 675 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 685 687 685 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 699 701 699 701 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 702 704 702 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 816 826 816 826 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rhodopsin </italic>
###xml 827 829 827 829 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 830 832 830 832 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 890 899 890 899 <italic xmlns:xlink="http://www.w3.org/1999/xlink">arrestin </italic>
###xml 900 902 900 902 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 941 945 934 938 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDE </italic>
###xml 946 948 939 941 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 949 951 942 944 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 1026 1030 1019 1023 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rho </italic>
###xml 1050 1059 1043 1052 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 1137 1145 1130 1138 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 1146 1148 1139 1141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 1149 1151 1142 1144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 1152 1154 1145 1147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 1161 1165 1154 1158 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crx </italic>
###xml 1169 1173 1162 1166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrl </italic>
###xml 1234 1238 1227 1231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crx </italic>
###xml 1367 1369 1360 1362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 1375 1379 1368 1372 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrl </italic>
###xml 1546 1548 1539 1541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 1582 1586 1575 1579 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CRX </italic>
###xml 1590 1594 1583 1587 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NRL </italic>
###xml 1728 1748 1721 1741 <italic xmlns:xlink="http://www.w3.org/1999/xlink">retinitis pigmentosa</italic>
###xml 1767 1777 1760 1770 <italic xmlns:xlink="http://www.w3.org/1999/xlink">amaurosis </italic>
###xml 1801 1803 1794 1796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 1804 1806 1797 1799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 228 243 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1248 1252 <span type="species:ncbi:10090">mice</span>
###xml 1329 1333 <span type="species:ncbi:10090">mice</span>
###xml 1389 1393 <span type="species:ncbi:10090">mice</span>
###xml 1502 1506 <span type="species:ncbi:10090">mice</span>
###xml 1618 1626 <span type="species:ncbi:9606">patients</span>
The proximal promoter regions of both Rho (-225 to +70 base pairs relative to the transcription start site) [11-13] and IRBP (-123 to +18 bp) [6,14] are sufficient to drive photoreceptor-specific expression of reporter genes in transgenic mice. Using DNAse I protection assays, binding sites for both retina-enriched and more widely expressed proteins have been identified on these promoters [15-22] and include both positive and negative regulatory elements [17-19,23-29]. Among the positive regulatory elements, Ret-1, BAT-1 and PCE-1 each contain a core ATTA sequence that can be bound by homeodomain containing transcription factors including CRX [30], RX/RAX [31], ERX [32], QRX [33] and OTX2 [18,34]. Binding sites for the basic-leucine zipper transcription factor NRL have been identified in the promoters of rhodopsin [35,36] as well as other photoreceptor-specific genes including arrestin [26] and the rod-specific alpha- and beta-PDE [37,38]. Combinatorial effects by CRX and NRL result in synergistic increases in Rho promoter activation in vitro that likely contribute to the high levels of expression in rod photoreceptors in vivo [29,30,39] Both Crx and Nrl play key roles in photoreceptor development and survival: in Crx knock-out mice, rod photoreceptors fail to elaborate outer segments and degenerate and the mice lack detectible visual function [40]; in Nrl knock-out mice, rod photoreceptors apparently fail to differentiate (although there is an increase in cone-like cells) and mice have severely reduced visual function [41]. In addition, mutations in both CRX and NRL have been identified in patients with a variety of inherited retinal degenerative diseases including autosomal dominant and recessive retinitis pigmentosa, Leber congenital amaurosis and cone-rod dystrophy [42-45].
###end p 10
###begin p 11
###xml 211 213 211 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 214 216 214 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 377 387 377 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rhodopsin </italic>
###xml 397 399 397 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 433 438 433 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IRBP </italic>
###xml 448 450 448 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 709 714 709 714 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IRBP </italic>
###xml 793 802 793 802 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 803 805 803 805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 855 857 855 857 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 868 870 868 870 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 893 895 893 895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 1197 1207 1197 1207 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rhodopsin </italic>
###xml 1211 1216 1211 1216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IRBP </italic>
###xml 1226 1235 1226 1235 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 1236 1238 1236 1238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
Although transcriptional repression plays an important role in development and cell fate determination in the central nervous system and inappropriate de-repression of gene expression can contribute to disease [46,47], relatively little is known about negative regulation of photoreceptor-specific gene expression. Negative regulatory elements, including the CRS-1 site in the rhodopsin promoter [21] and the G-rich repressor in the IRBP promoter [20] are bound by nuclear proteins present in both retinal and non-retinal tissues, although the identities of the specific transcription factors have not been established. The zinc-finger transcription factor MOK2 binds to sites in the promoter and intron 1 of IRBP and represses transactivation of reporter constructs containing these elements in vitro [48]. Other proteins interact with CRX (e.g. ATXN-7 [49] and BAF [50]) or NRL (e.g. FIZ-1 [51]) and can reduce their ability to activate transcription, but these appear to repress via protein/protein interactions rather than binding directly to the promoter. We recently identified KLF15, a member of the Sp/KLF family of zinc-finger containing transcription factors, as a repressor of both the rhodopsin and IRBP promoters in vitro [52].
###end p 11
###begin p 12
###xml 147 154 147 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Kr&#252;ppel</italic>
###xml 199 201 199 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 202 204 202 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 423 425 423 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B55">55</xref>
###xml 426 428 426 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B56">56</xref>
###xml 485 489 485 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rho </italic>
###xml 493 498 493 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IRBP </italic>
###xml 509 511 509 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 537 544 537 544 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Clc-K1 </italic>
###xml 548 555 548 555 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Clc-K2 </italic>
###xml 566 568 566 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 588 594 588 594 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Glut4 </italic>
###xml 628 630 628 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 644 646 644 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B57">57</xref>
###xml 647 649 647 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B58">58</xref>
###xml 658 660 658 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B59">59</xref>
###xml 673 675 673 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 704 712 704 712 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 1072 1076 1072 1076 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rho </italic>
###xml 1080 1085 1080 1085 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IRBP </italic>
KLF15 is expressed in both retinal and non-retinal tissues and, like other members of the Sp/KLF family, is characterized by the presence of three Kruppel-type zinc-finger domains at the C-terminus [52-54]. Members of this gene family have been characterized as regulators of both tissue-specific and ubiquitous genes and can function as either transcriptional activators, repressors or both depending on promoter context [55,56] KLF15 appears to be bi-functional, as it represses the Rho and IRBP promoters [52] and the kidney-specific Clc-K1 and Clc-K2 promoters [53] but activates the Glut4 (glucose transporter 4) promoter [54]. KLF1/EKLF [57,58], KLF8 [59] and KLF15 [54] all bind a core CACCC site in vitro, although this is shorter than the 9 bp site predicted for a three zinc-finger containing protein and is likely to provide only limited specificity. To gain further insight into the mechanism of KLF15-mediated regulation of gene expression, we have characterized the binding characteristics and specificity of KLF15 and defined the KLF15 binding sites in the Rho and IRBP promoters.
###end p 12
###begin title 13
Results
###end title 13
###begin title 14
EMSA analysis of KLF15 binding
###end title 14
###begin p 15
###xml 731 733 731 733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 112 117 <span type="species:ncbi:9606">human</span>
DNA binding properties of KLF15 were analyzed by electrophoretic mobility shift assays (EMSA) using GST-tagged, human KLF15 fusion protein. Constructs for the full-length KLF15 fusion protein expressed poorly in bacterial cells and yielded a highly degraded protein. Therefore, a recombinant fusion protein (KLF15-ZF) containing the C-terminal 123 amino acids including the three C-terminal zinc-finger domains fused to GST was expressed and purified from bacteria. Western blot of crude bacterial lysates using anti-GST antibodies showed minor degradation of the fusion protein prior to purification; however, the majority of the protein recovered following affinity purification consisted of intact KLF15-ZF fusion protein (Fig. 1A).
###end p 15
###begin p 16
###xml 89 93 89 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rho </italic>
###xml 177 179 177 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 254 264 254 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rhodopsin </italic>
###xml 380 382 380 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 401 403 401 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 506 508 506 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 517 519 517 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1D</xref>
###xml 534 536 534 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1E</xref>
###xml 82 88 <span type="species:ncbi:9913">bovine</span>
###xml 131 136 <span type="species:ncbi:4932">yeast</span>
###xml 248 253 <span type="species:ncbi:9606">human</span>
Comparison of the proximal promoter regions showed that the 29 bp fragment of the bovine Rho promoter (bRho29) used as bait in the yeast one-hybrid assay that identified KLF15 [52] shared high sequence identity with the equivalent element from the human rhodopsin promoter (hRho29), differing by only 5 bp. In EMSA, KLF15-ZF fusion protein shifted oligomers for both bRho29 (Fig. 1B) and hRho29 (Fig. 1C) and these could be supershifted by addition of antibodies against KLF15 (generous gift of S. Uchida [53]) (Fig. 1D) or GST (Fig. 1E). The lower molecular weight band that was supershifted by the anti-KLF15 but not by anti-GST antibodies most likely resulted from low levels of protein that had lost the N-terminal, GST-tag, but retained the C-terminus of the protein containing the DNA binding domain and the anti-KLF15 antibody recognition site.
###end p 16
###begin title 17
Zinc dependence of KLF15 binding
###end title 17
###begin p 18
###xml 123 126 123 126 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+2 </sup>
###xml 178 180 178 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B60">60</xref>
###xml 181 183 181 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B61">61</xref>
###xml 240 243 240 243 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+2 </sup>
###xml 389 391 389 391 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 545 550 545 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A, B</xref>
###xml 768 770 768 770 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 776 778 776 778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 823 825 823 825 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 831 833 831 833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 1003 1005 1003 1005 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+2</sup>
###xml 1091 1093 1091 1093 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2C</xref>
###xml 1346 1367 1346 1367 <italic xmlns:xlink="http://www.w3.org/1999/xlink">retinitis pigmentosa </italic>
###xml 1368 1370 1368 1370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B62">62</xref>
###xml 1371 1373 1371 1373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B63">63</xref>
###xml 1522 1524 1522 1524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B64">64</xref>
###xml 1525 1527 1525 1527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B65">65</xref>
###xml 1642 1649 1642 1649 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
The secondary structure of zinc-finger domains and as well as their ability to bind DNA is dependent on the chelation of Zn+2 ions by Cys2-His2 residues within each zinc finger [60,61]. To determine if DNA binding by KLF15-ZF was in fact Zn+2 dependent, aliquots of the fusion protein were diluted in EDTA to chelate divalent cations and subsequently added to binding reactions containing 32P-labeled bRho29 or hRho29 oligonucleotides. Increasing concentrations of EDTA resulted in a dose-dependent reduction in KLF15-ZF binding to bRho29 (Fig. 2A, B) or to hRho29 (data not shown), with binding completely eliminated when protein was prepared in 50 mM EDTA, resulting in 20 mM EDTA in the final binding reaction. DNA binding was reconstituted by addition of 5 mM ZnCl2 (Fig. 2A) or ZnAcetate (data not shown), but not MgCl2 (Fig. 2B) to the binding reactions. As an additional test of cation specificity, we tested KLF15 binding activity in the presence of EGTA, a chelator that preferentially binds Ca+2. No loss of KLF15-ZF binding was observed in the presence of up to 250 mM EGTA (Fig. 2C). It is interesting to note that the retina and other ocular tissues contain unusually high levels of zinc compared to other tissues and zinc deficiency has been implicated with various retinopathies including macular degeneration, night blindness and retinitis pigmentosa [62,63]. Chelation of intracellular zinc can modulate conformation and DNA binding activity of the zinc-finger transcription factor p53 in cultured cells [64,65]; therefore, physiological zinc deficiencies could result in loss of DNA binding activity of zinc-finger proteins in vivo.
###end p 18
###begin title 19
Sequence specificity of KLF15 binding
###end title 19
###begin p 20
###xml 121 122 121 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 440 442 440 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 525 526 525 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
Sequence specificity of KLF15-ZF binding was examined by EMSA using a series of unlabeled oligomers as competitors (Fig. 3). The addition of 250-fold excess of cold bRho29 or hRho29 effectively competed with the radiolabeled bRho29 probe for KLF15 binding. We also tested oligomers IRBP1 and IRBP2 that contained binding sites for the zinc-finger transcription factor MOK2 and are located in the promoter and intron 2 of IRBP respectively [48]. Neither of these heterologous oligomers competed with radiolabeled bRho29 (Fig. 3) or hRho29 probes (data not shown).
###end p 20
###begin p 21
###xml 182 184 182 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 553 555 553 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 573 575 573 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4C</xref>
###xml 450 456 <span type="species:ncbi:9913">bovine</span>
###xml 471 476 <span type="species:ncbi:9606">human</span>
To identify the specific bases within bRho29 and hRho29 that were critical for binding, we generated a series of scanning oligomers, each containing a triplet of mutated bases (Fig. 4A). Because an individual zinc-finger domain typically binds to a DNA triplet, this approach was selected to maximize the likelihood that the mutations would disrupt protein/DNA interactions. Oligomers with 1 or more mutated bases within the central C-rich sequence (bovine: ACG CCC CCA; human ACA CCC CCA) had reduced ability to compete with the wild-type bRho29 (Fig. 4B) or hRho29 (Fig. 4C), whereas oligomers with mutations of any other triplet competed as well as wild-type.
###end p 21
###begin p 22
###xml 221 223 217 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 271 272 267 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 845 847 833 835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
To test if there was binding activity in retinal proteins that was specific to the KLF15 binding site, we performed EMSA using a total retinal extract with either the wild-type bRho29 oligo or the Delta10 oligo (see Fig. 4A) containing a mutated KLF15 binding site (Fig. 5). With both the wild-type and mutant oligos, there were multiple shifted bands observed, however mutation of the KLF15 binding site eliminated several of the major bands. Bands that were unique to the wild-type oligo were not abolished by the addition of up to 200-fold excess of the Delta10 oligo as a competitor, while those that were common to both were reduced in intensity to near background levels. This is consistent with our findings that Delta10 was unable to compete with the wild-type bRho29 for binding to the KLF15-ZF fusion protein in competitive EMSA (Fig. 4B). We observed that with the wild-type oligo, those bands that were dependent on the presence of an intact KLF15 binding site showed the greatest intensity; in contrast, when the KLF15 binding site was mutated, those bands that were not dependent on the presence of the KLF15 binding site were increased in intensity.
###end p 22
###begin title 23
KLF15 binding sites in rhodopsin and IRBP promoters
###end title 23
###begin p 24
###xml 76 80 76 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rho </italic>
###xml 84 89 84 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IRBP </italic>
###xml 360 365 360 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6 A&#8211;D</xref>
###xml 375 380 375 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IRBP </italic>
###xml 488 493 488 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7A, B</xref>
###xml 615 618 615 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F10">10A</xref>
###xml 832 834 832 834 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B66">66</xref>
###xml 944 962 944 962 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">Additional file: 1</xref>
###xml 69 75 <span type="species:ncbi:9913">bovine</span>
###xml 139 145 <span type="species:ncbi:9913">bovine</span>
DNAse I footprinting was used to identify KLF15 binding sites in the bovine Rho and IRBP promoters. Using two overlapping fragments of the bovine RPPR (-225 to + 70 bp and -315 to -31 bp) as templates, KLF15-ZF protected six distinct sites (designated KR-a to KR-f) that were generally similar in their boundaries on both the forward and reverse strands (Fig. 6 A-D). In the IRBP proximal promoter, KLF15 protected three sites (KI-a, KI-b, KI-c) on both forward and reverse strands (Fig. 7A, B). Examination of the sequences protected by KLF15-ZF showed that all contained extended C-rich or G-rich sequences (Fig. 10A), consistent with the site identified by competitive EMSA. To identify a consensus binding site, we analyzed the sequences of the C-rich strands of the nine KLF15 protected regions using Target Explorer software [66]. Assuming a 60% AT, 40% GC content in the genome and a 9 bp binding site, we identified the top 4 matrices (Additional file: 1). All of the matrices included the site identified by competitive EMSA and, when used to evaluate the oligos tested in competitive EMSA, could discriminate between the strong competitors and weak/non-competitors.
###end p 24
###begin p 25
###xml 101 103 101 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F10">10</xref>
###xml 503 513 503 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rhodopsin </italic>
###xml 519 521 519 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8A</xref>
###xml 527 532 527 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IRBP </italic>
###xml 538 540 538 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8B</xref>
###xml 628 629 628 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8</xref>
###xml 640 658 640 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">Additional file: 1</xref>
###xml 737 747 737 747 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rhodopsin </italic>
###xml 1079 1084 1079 1084 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IRBP </italic>
###xml 547 552 <span type="species:ncbi:9606">human</span>
###xml 561 564 <span type="species:ncbi:9615">dog</span>
###xml 566 571 <span type="species:ncbi:10090">mouse</span>
###xml 576 579 <span type="species:ncbi:10116">rat</span>
###xml 812 815 <span type="species:ncbi:9615">dog</span>
###xml 1047 1052 <span type="species:ncbi:10090">mouse</span>
###xml 1057 1060 <span type="species:ncbi:10116">rat</span>
###xml 1127 1133 <span type="species:ncbi:9913">bovine</span>
###xml 1135 1140 <span type="species:ncbi:9606">human</span>
###xml 1152 1155 <span type="species:ncbi:9615">dog</span>
###xml 1198 1203 <span type="species:ncbi:10090">mouse</span>
###xml 1233 1239 <span type="species:ncbi:9913">bovine</span>
###xml 1244 1247 <span type="species:ncbi:9615">dog</span>
Matrix 2 yielded the greatest difference between the scores of competitors and non-competitors (Fig. 10). Possible scores ranged from -17.45 to 10.65, with the scores for the KLF15 protected sites ranging from 7.26 to 10.27. Oligos that were good competitors in EMSA all contained at least one binding site with a score > 5.68, whereas those that were poor competitors had maximal scores < 4.06. Using 1/2 of the difference between these scores as a cutoff (4.87), we analyzed the proximal promoters of rhodopsin (Fig. 8A) and IRBP (Fig. 8B) from human, chimp, dog, mouse and rat to identify potential KLF15 binding sites (Fig. 8; see also Additional file: 1). These analyses showed that the KR-a site was conserved across all mammalian rhodopsin promoters analyzed, and the KR-d site was present in all but the dog promoter, which contained an additional KLF15 binding site immediately 5' to KR-e. The other four KLF15 binding sites were conserved only in non-rodents, although one novel binding site located 3' to site KR-d was predicted in the mouse and rat promoters. In the IRBP promoters, KI-b and KI-c were conserved in bovine, human, chimp and dog, with an additional site predicted in the mouse promoter (5' to KI-a) and in bovine and dog (5' to KI-c, outside of the region analyzed by DNAse I footprinting).
###end p 25
###begin title 26
###xml 30 36 <span type="species:ncbi:9913">bovine</span>
Effects of KLF15 on a minimal bovine rhodopsin promoter
###end title 26
###begin p 27
###xml 157 167 157 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rhodopsin </italic>
###xml 177 179 177 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 295 305 295 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rhodopsin </italic>
###xml 530 532 530 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 613 623 613 623 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rhodopsin </italic>
###xml 922 923 922 923 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9</xref>
###xml 1045 1047 1045 1047 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9B</xref>
###xml 1227 1229 1227 1229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9C</xref>
###xml 1359 1361 1359 1361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 150 156 <span type="species:ncbi:9913">bovine</span>
###xml 523 528 <span type="species:ncbi:9031">chick</span>
We previously reported that KLF15 repressed transactivation of bRho225-luc, a promoter-luciferase reporter construct containing -225 to +70 bp of the bovine rhodopsin promoter [52] that contained the six KLF15 binding sites identified in DNAse I footprinting analysis. A smaller fragment of the rhodopsin proximal promoter (-130 to +70 bp) containing only four KLF15 binding sites, but lacking the KR-e/CRS-1 and KR-f sites, is still sufficient to drive expression of a reporter gene in primary cultures retinal cells from chick [36]. Using a luciferase reporter construct containing this smaller fragment of the rhodopsin promoter (bRho130-luc), the results of transient transfections of 293 cells were qualitatively similar to those previously reported using the bRho225-luc construct: KLF15 alone or in co-transfections with CRX and/or NRL resulted in statistically significant decreases in luciferase expression (Fig. 9). In co-transfections with CRX, high concentrations of KLF15 were more effective at reducing luciferase expression (Fig. 9B); in contrast, there was a relatively concentration-independent reduction (>50%) in luciferase expression in co-transfections with NRL at all concentrations of KLF15 tested (Fig. 9C). We compared the results of promoter transactivation assays using bRho130-luc with those previously obtained using bRho225-luc [52] and found that luciferase expression in transfections with KLF15 was consistently lower with bRho225-luc than with bRho130-luc, with the differences within the 95% confidence interval for KFL15+CRX (p = 0.0355) and within 90% confidence interval for KLF15 alone (p = 0.0879), KLF15+NRL (p = 0.0594) and KLF15+CRX+NRL (p = 0.0894).
###end p 27
###begin title 28
Discussion
###end title 28
###begin p 29
###xml 69 79 69 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rhodopsin </italic>
###xml 83 88 83 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IRBP </italic>
###xml 98 107 98 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 399 401 399 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 556 558 556 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B67">67</xref>
###xml 559 561 559 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B68">68</xref>
###xml 851 853 851 853 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 1849 1851 1849 1851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 1852 1854 1852 1854 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B57">57</xref>
###xml 1855 1857 1855 1857 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B59">59</xref>
###xml 1952 1954 1952 1954 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 242 248 <span type="species:ncbi:9913">bovine</span>
###xml 277 282 <span type="species:ncbi:9606">human</span>
###xml 788 793 <span type="species:ncbi:9606">human</span>
###xml 797 800 <span type="species:ncbi:10116">rat</span>
###xml 1016 1022 <span type="species:ncbi:9913">bovine</span>
###xml 1042 1047 <span type="species:ncbi:9606">human</span>
###xml 1056 1059 <span type="species:ncbi:9615">dog</span>
###xml 1061 1066 <span type="species:ncbi:10090">mouse</span>
###xml 1071 1074 <span type="species:ncbi:10116">rat</span>
###xml 1255 1260 <span type="species:ncbi:9606">human</span>
###xml 1265 1271 <span type="species:ncbi:9913">bovine</span>
###xml 1439 1444 <span type="species:ncbi:9606">human</span>
###xml 1507 1513 <span type="species:ncbi:9913">bovine</span>
###xml 1517 1522 <span type="species:ncbi:9606">human</span>
We previously identified KLF15 as a transcriptional repressor of the rhodopsin and IRBP promoters in vitro and report here the characterization of KLF15's DNA binding properties. For these analyses, we analyzed protein binding specificity on bovine promoters using a truncated human KLF15-GST fusion protein containing the C-terminal DNA binding domain, but lacking the N-terminal repressor domain [52]. Since zinc-finger domains typically function as modular DNA binding motifs that can bind their target sequences independently of other protein domains [67,68], the binding specificity of the truncated KLF15 fusion protein is predicted to be similar, if not identical, to the full length protein. Previous studies showed that recombinant GST fusion proteins containing the full length human or rat KLF15 bound to an element in the CLC-K1 promoter [53] and we found that our truncated KLF15 fusion protein also bound the same element in EMSA (data not shown). The amino acid sequence of the zinc finger domains of bovine KLF15 differs from human, chimp, dog, mouse and rat at only a single amino acid residue (isoleucine to valine) and the flanking regions that were included in the KLF15-ZF fusion protein differ at only 11 amino acid residues between human and bovine KLF15. We would predict, therefore, that the DNA binding specificity would show only minor differences (if any) between these species. Supporting this prediction, the human KLF15-GST fusion protein shifted oligos containing either the bovine or human KLF15 consensus site. Using EMSA, we have confirmed that proteins present in retinal extracts can bind specifically to the KLF15 binding site. However, this result does not necessarily mean that the observed binding activity is attributable to KLF15. Other members of the KLF family recognize similar G/C rich binding motifs [54,57-59] and MAZ (myc-associated zinc-finger protein) can also recognize the KLF15 core binding site [53]. Thus, it remains a distinct possibility that, in addition to KLF15, there are other retinal proteins that can recognize this site.
###end p 29
###begin p 30
###xml 289 299 289 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rhodopsin </italic>
###xml 309 311 309 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 504 506 504 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 554 564 554 564 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rhodopsin </italic>
###xml 620 622 620 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 668 670 668 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B69">69</xref>
###xml 821 823 821 823 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 824 826 824 826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 1124 1126 1124 1126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 1194 1196 1194 1196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 1197 1199 1197 1199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 1217 1227 1217 1227 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rhodopsin </italic>
###xml 1275 1277 1275 1277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 1411 1418 1411 1418 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 1424 1433 1424 1433 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 1487 1497 1487 1497 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rhodopsin </italic>
###xml 547 553 <span type="species:ncbi:9913">bovine</span>
###xml 605 611 <span type="species:ncbi:9913">bovine</span>
###xml 746 752 <span type="species:ncbi:9913">bovine</span>
Several of the KLF15 binding sites that we identified in DNAse I footprinting correspond to previously identified promoter elements. In EMSA, both retina-specific and ubiquitous nuclear proteins bind a 20 bp probe (-55 to -36) containing the Ret-4 element (including the KR-b site) in the rhodopsin promoter [24]. Interestingly, mutations in the G-rich sequence within the Ret-4 element that would be predicted to disrupt the KLF15 binding site eliminated binding by the ubiquitously expressed proteins [24]. In DNAse I footprinting assays of the bovine rhodopsin proximal promoter, nuclear extracts from bovine retina [21] and from Y79 and WERI retinoblastoma cells [69] protected the BAT-1 (-103 to -84) site. Two additional sites protected by bovine retinal proteins are Ret-1 (-138 to -126) and CRS-1 (-177 to -199) [16,20]. Three of these sites correspond to sites protected by KLF15 in our DNAse I footprinting, KR-6/Ret-4, KR-c/BAT-1 and KR-e/CRS-1. In addition to being protected by nuclear proteins from retinal extract, the CRS-1 site is protected by proteins present in nuclear extracts from non-retinal tissues [21]. KLF15 is expressed in the multiple tissues including the retina [52-54] and can repress rhodopsin promoter constructs in transient transfections [52]. Although we do not yet know the relative importance of these different KLF15 binding sites in regulation of target gene expression in vivo, our in vitro assays showed that KLF15 more effectively repressed a rhodopsin promoter construct (bRho225) containing six KLF15 binding sites (including KR-e/CRS-1) than a shorter promoter construct (bRho130) that contains only 4 (including the KR-b/Ret-4 and KR-c/BAT-1 sites), suggesting that both the proximal and distal sites influence KLF15's repressor activity.
###end p 30
###begin p 31
###xml 67 72 67 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IRBP </italic>
###xml 218 220 218 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 221 223 221 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 224 226 224 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 321 336 321 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus laevis </italic>
###xml 337 339 337 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 492 494 492 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 670 678 670 678 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 679 681 679 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 722 727 722 727 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IRBP </italic>
###xml 746 754 746 754 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 902 904 902 904 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 978 985 978 985 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 321 335 <span type="species:ncbi:8355">Xenopus laevis</span>
The G-rich repressor element is located between -156 and -70 bp in IRBP promoter and overlaps the KI-c binding site for KLF15. Deletion of the G-rich element increases reporter gene expression in retinoblastoma cells [14,19,34] and results in inappropriate expression of GFP reporter constructs in non-retinal tissues in Xenopus laevis [28]. In DNAse I footprinting, this site is protected by proteins present in nuclear extracts from both retinoblastoma WERI-Rb1 and non-retinal HeLa cells [18]. Based on the ability of oligos containing the Sp1 consensus site to compete with the G-rich element in EMSA, it was proposed that Sp1 or Sp1-related proteins bind this site in vivo [19]. KLF15 represses transactivation of an IRBP promoter construct in vitro, is expressed in both retinal and non-retinal tissues, and is structurally and phylogenetically related to the Sp family of transcription factors [52], making it an attractive candidate to bind the G-rich repressor element in vivo.
###end p 31
###begin p 32
###xml 1071 1073 1071 1073 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B70">70</xref>
###xml 1175 1183 1175 1183 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 1322 1329 1322 1329 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 93 99 <span type="species:ncbi:9913">bovine</span>
###xml 101 106 <span type="species:ncbi:9606">human</span>
###xml 118 121 <span type="species:ncbi:9615">dog</span>
###xml 258 263 <span type="species:ncbi:10090">mouse</span>
###xml 267 270 <span type="species:ncbi:10116">rat</span>
###xml 894 899 <span type="species:ncbi:9606">human</span>
###xml 904 909 <span type="species:ncbi:10090">mouse</span>
###xml 962 967 <span type="species:ncbi:9606">human</span>
###xml 1024 1029 <span type="species:ncbi:10090">mouse</span>
Potential KLF15 binding sites corresponding to the CRS-1 and G-rich sites are present in the bovine, human, chimp and dog promoters. It was, however, somewhat surprising that no consensus KLF15 binding sites were identified at corresponding locations in the mouse or rat promoters. As the zinc-finger domains are identical between these species, it seems unlikely that the lack of identifiable binding sites at these locations reflects species-specific differences in KLF15's binding specificity. Although we cannot formally exclude this possibility, there are several possible alternative interpretations of this observation. The simplest explanation is that the location or number of KLF15 binding sites differs between species, possibly reflecting the accumulation of mutations during evolution. A comparison of well characterized promoters of 51 genes found substantial differences between human and mouse, with 32-40% of the binding sites identified in the human promoters containing sufficient sequence changes in the mouse promoters to render them non-functional [70]. In addition, despite our evidence showing that KLF15 binds the CRS-1 and G-rich repressor elements in vitro, there may be species-specific differences in the identity and/or sequence specificity of the transcription factor(s) that bind this site in vivo.
###end p 32
###begin p 33
###xml 131 133 131 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B71">71</xref>
###xml 667 676 667 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rhodopsin</italic>
###xml 678 682 678 682 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IRBP</italic>
###xml 684 692 684 692 <italic xmlns:xlink="http://www.w3.org/1999/xlink">arrestin</italic>
###xml 704 715 700 711 <italic xmlns:xlink="http://www.w3.org/1999/xlink">transducin </italic>
###xml 729 733 721 725 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PDE </italic>
###xml 853 854 845 846 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 1011 1012 1003 1004 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 1013 1014 1005 1006 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 1015 1017 1007 1009 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B72">72</xref>
###xml 1117 1127 1109 1119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rhodopsin </italic>
###xml 1293 1295 1285 1287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 1357 1367 1349 1359 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rhodopsin </italic>
###xml 1404 1405 1396 1397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 1677 1679 1669 1671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B73">73</xref>
###xml 209 213 <span type="species:ncbi:9913">cows</span>
###xml 225 229 <span type="species:ncbi:9615">dogs</span>
###xml 636 642 <span type="species:ncbi:9913">bovine</span>
###xml 873 877 <span type="species:ncbi:10090">mice</span>
###xml 882 886 <span type="species:ncbi:10116">rats</span>
###xml 1234 1240 <span type="species:ncbi:9913">bovine</span>
###xml 1524 1529 <span type="species:ncbi:10090">mouse</span>
###xml 1623 1628 <span type="species:ncbi:10090">mouse</span>
###xml 1661 1666 <span type="species:ncbi:9606">human</span>
Changes in transcriptional regulation are thought to play a significant role in generating phenotypic differences between species [71] and there are clearly morphological and developmental differences between cows, primates, dogs and rodents. In the retina, differences include the time course of embryonic/fetal development and cellular differentiation, as well as the proportions and absolute numbers of different neuronal subtypes (e.g. rods vs. cones) present in the mature retina. Along with these morphological differences, there are species-specific variations in the regulation of photoreceptor-specific gene expression. In the bovine retina, transcripts for rhodopsin, IRBP, arrestin, rod alpha-transducin and rod alpha-PDE all begin to accumulate relatively late in retinal development, at the time when the first outer segments are detected [7]. In contrast, in mice and rats there is considerable variation in the developmental stage when different photoreceptor-specific genes are first expressed [8,9,72]. Interestingly, the CRS-1/KR-e site was initially proposed to play a role in repressing premature rhodopsin expression during retinal development, based on the observation that protection of the CRS-1 site by fetal bovine retinal proteins diminishes throughout development [21] in a temporal pattern that is coordinated with increases in rhodopsin transcription and mRNA accumulation [9]. Further emphasizing the extent of the differences between species, a large scale analysis of expressed genes in the mouse retina found that out of nearly 2000 known genes that could be assigned map locations in the mouse genome, 25% had no identifiable human ortholog [73]. Although the identification and characterization of conserved genes and regulatory mechanisms has provided significant contributions to our understanding of retinal development and disease, there are likely to be novel and potentially valuable insights that can be obtained through comparative analysis of the basis of species-specific differences.
###end p 33
###begin p 34
###xml 67 69 67 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B57">57</xref>
###xml 70 72 70 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B59">59</xref>
###xml 99 101 99 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 242 244 242 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B67">67</xref>
###xml 594 603 594 603 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a priori </italic>
###xml 1001 1003 1001 1003 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 1004 1006 1004 1006 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 1179 1181 1179 1181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 1337 1339 1337 1339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 1725 1726 1721 1722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 2425 2435 2417 2427 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rhodopsin </italic>
###xml 2451 2460 2443 2452 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 2556 2558 2548 2550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 2591 2599 2583 2591 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 2660 2670 2652 2662 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rhodopsin </italic>
Several KLF proteins have been shown to bind a core CACCC element [57-59] and Gray and colleagues [54] demonstrated that 5'-CACCC-3' is sufficient for KLF15 binding in EMSA. A single zinc finger typically makes contact with 3 adjacent bases [67] therefore the three zinc-fingers of KLF15 would be predicted to have a 9 bp binding site, consistent with our EMSA results. We found that mutations outside of the 9 bp consensus site had no effect on DNA binding in EMSA; however, when we used TargetExplorer to re-analyze the KLF15 protected sequences identified in DNAse I footprinting, making no a priori assumptions as to the actual size of the consensus binding site, a longer 12-13 bp consensus sequence was identified. The functional significance of the extended consensus site is unclear, but it is interesting to note that the KR-b, KR-c and KR-d sites respectively overlapped the Ret-4, BAT-1 and Ret-1 sites, all containing known binding sites for homeodomain containing proteins including CRX [30,31]. The KR-b site is located at the 3' end of the Ret-4 site within a G-rich sequence is a binding site for nuclear proteins present in both retinal and non-retinal tissues [24]. The highly conserved KR-d site is within a GC-rich sequence that functions to facilitate binding of retinal nuclear proteins to the adjacent Ret-1 site [15]. One interpretation is that KLF15 binding sites are preferentially located adjacent to binding sites for other transcription factors, possibly CRX or other OTX-related factors. In EMSA using total retinal proteins, mutation of the KLF15 binding site increased binding of some retinal proteins to the Delta10 oligo, as shown by the increased intensity of KLF15-independent bands (Fig. 5). As mutation of the KLF15 binding site does not alter the core homeodomain binding site present in these oligos, homeodomain proteins (e.g. CRX; RX/RAX; OTX2) present in retinal extracts likely bind to both the wild-type and mutant oligos. Although mutation of the KLF15 site may have inadvertently created a novel protein binding site, several of the bands showing increased intensity with the Delta10 oligo were also present using the wild-type bRho29 oligo, raising the possibility that occupancy of the KLF15 site can affect protein/DNA interactions of other DNA binding proteins. The proximity of KLF15 and CRX binding sites and our findings that (1) KLF15 can repress transactivation of the rhodopsin promoter by CRX in vitro and (2) both KFL15 and CRX are expressed in non-photoreceptor cells in the inner nuclear layer [52] are consistent with a possible in vivo role for KLF15 in repressing inappropriate activation of the rhodopsin promoter by CRX in non-photoreceptor cells.
###end p 34
###begin p 35
###xml 284 289 284 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IRBP </italic>
###xml 319 321 319 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B74">74</xref>
###xml 322 324 322 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B75">75</xref>
###xml 815 817 812 814 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B76">76</xref>
###xml 1059 1061 1056 1058 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B77">77</xref>
###xml 1115 1125 1112 1122 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rhodopsin </italic>
###xml 152 158 <span type="species:ncbi:9913">bovine</span>
A similar correlation between KLF15 and CRX binding sites was not observed in the IRBP promoter. However, the KI-c site/G-rich repressor element in the bovine IRBP promoter is adjacent to a CpG dinucleotide (-115) that becomes hypomethylated specifically in retinal cells at the time IRBP expression is first detected [74,75]. The G-rich repressor element is bound by proteins present in non-retinal tissues where the CpG dinucleotide remains methylated; therefore, it is tempting to speculate that KLF15 may participate in regulating methylation at this site. Other KLF genes are known to regulate chromatin remodeling. The transcriptional activator KLF1/EKLF recruits a SWI/SNF-related chromatin remodeling complex that is thought to be involved in regulation of the locus control region of the beta-globin gene [76]. The transcriptional repressor KLF14/BTEB3 interacts with a co-repressor (mSin3A) and the histone deacetylase protein HDAC-1 though repressor domains within the N-terminus to mediate transcriptional repression through chromatin remodeling [77]. Interestingly, in our footprinting analysis of the rhodopsin promoter we observed several sites of increased DNAse I hypersensitivity adjacent to KLF15 protected regions, possibly reflecting alterations in DNA configuration and potentially lending additional support for involvement of KLF15 in chromatin remodeling.
###end p 35
###begin title 36
Conclusion
###end title 36
###begin p 37
###xml 138 142 138 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rho </italic>
###xml 146 151 146 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IRBP </italic>
###xml 336 346 336 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rhodopsin </italic>
###xml 350 355 350 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IRBP </italic>
###xml 754 762 754 762 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
The goal of these studies was to determine the binding characteristics and specificity of KLF15 and define the KLF15 binding sites in the Rho and IRBP promoters in order to gain further insight into the mechanism of KLF15-mediated regulation of retinal gene expression. We found that KLF15 binds to multiple 9 bp consensus sites in the rhodopsin and IRBP promoters including the previously identified CRS-1 and G-rich repressor elements. The presence of multiple KLF15 binding sites suggests that transcriptional repression is likely to play an important role in regulation of photoreceptor-specific genes. Based on the known expression of KLF15 in retinal and non-retinal tissues and the absence of KLF15 expression in photoreceptors, we hypothesize an in vivo role for KLF15 in repressing photoreceptor-specific gene expression in non-photoreceptor cells.
###end p 37
###begin title 38
Methods
###end title 38
###begin title 39
Protein isolation
###end title 39
###begin p 40
###xml 131 133 131 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 493 501 493 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 44 49 <span type="species:ncbi:9606">human</span>
###xml 493 500 <span type="species:ncbi:110766|species:ncbi:562">E. coli</span>
To generate KLF15-ZF-GST, the 3' end of the human KLF15 coding region (369 bp) and the stop codon was amplified from pCRII-hKLF15 [52] using a combination of Taq (Invitrogen; Carlsbad, California) and PFU polymerase (Promega; Madison, WI), subcloned into the BamHI/EcoRI sites of pGEX (Amersham/Pharmacia; Piscataway, NJ) and confirmed by sequencing. KLF15-ZF fusion protein with an N-terminal, glutathione-S-transferase (GST) tag was purified from whole cell lysates of IPTG-induced (0.4 mM) E. coli (BL21S; Invitrogen; Carlsbad, California) using sepharose 4B (Amersham/Pharmacia; Piscataway, NJ) according to maunfacturer's instructions. Purified protein was quantified using bicinchoninic acid protein assay kit (BCA; Sigma; St. Louis, MO) and analyzed using standard 10% SDS-polyacrylamide gel electrophoresis and Western blot with anti-GST antibodies (Amersham/Pharmacia; Piscataway, NJ) diluted 1:8000.
###end p 40
###begin p 41
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 308 312 <span type="species:ncbi:10090">mice</span>
Mice used for protein isolation were handled in accordance with the Association for Research in Vision and Ophthalmology Statement for the Use of Animals and methods were approved by the Animal Care and Use Committee of Johns Hopkins University. For total protein extracts, retinas were dissected from adult mice and placed directly into ice cold PBS containing protease inhibitors (CompleteMini Tablets, EDTA-free; Roche, Indianapolis, IN), sonicated for 10-15 seconds (Setting 5, 50% Duty Cycle) using a Branson Model 250 Sonifier (Branson Ultrasonics Corp., Danbury, CT) with a micro-tip, quantified by BCA and stored at -80C.
###end p 41
###begin title 42
Electrophoretic mobility shift assays (EMSA)
###end title 42
###begin p 43
###xml 53 55 53 55 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 56 58 56 58 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B78">78</xref>
###xml 180 181 180 181 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 238 241 238 241 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+2 </sup>
###xml 258 260 258 260 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 463 465 463 465 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 819 821 819 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
EMSA assays followed previously published protocols [24,78] and used a binding buffer optimized for the KLF15-ZF-GST fusion protein (4 mM HEPES, 5 mM EGTA; 100 mM KCl, 0.25 mM ZnCl2; 0.02% NP40; 0.1 M DTT; 4% glycerol). For analysis of Zn+2 specificity, ZnCl2 was eliminated from the binding buffer except as indicated. Probes with 5'-GG dinucleotide overhangs were generated by annealing single-stranded oligos with their reverse complement and end-labeled with 32P-dCTP using Klenow fragment of DNA polymerase (New England Biolabs, Beverly MA). Cold competitors were end-filled with Klenow using cold dCTP. Binding reactions were incubated for 90 to 120 minutes on ice; for supershift experiments antibodies against GST (Amersham/Pharmacia; Piscataway, NJ) or KLF15 C-terminal peptide [a generous gift of S. Uchida; [53]] were added after an initial 60 minute incubation. Following polyacrylamide gel electrophoresis on a 5% non-denaturing gel, dried gels were exposed to storage phosphor screens; peaks for each band and DLU (Digital Light Units) for the areas under the peaks were determined using Optiquant software (Packard Instruments). For each lane, the percent of oligo shifted was calculated as [(DLU shifted band/ total DLU) x 100]. For competition assays, "percent competed" was calculated as the difference between the percent oligo shifted without competitor and the percent oligo shifted with competitor.
###end p 43
###begin title 44
DNAse I footprint analysis
###end title 44
###begin p 45
###xml 63 65 63 65 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 66 68 66 68 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B78">78</xref>
###xml 76 78 76 78 <sup xmlns:xlink="http://www.w3.org/1999/xlink">33</sup>
###xml 224 228 224 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rho </italic>
###xml 306 310 306 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rho </italic>
###xml 338 340 338 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 354 359 354 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IRBP </italic>
###xml 473 478 473 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IRBP </italic>
###xml 488 490 488 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 578 582 578 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rho </italic>
###xml 682 686 682 686 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rho </italic>
###xml 789 793 789 793 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IRBP</italic>
###xml 217 223 <span type="species:ncbi:9913">bovine</span>
###xml 290 296 <span type="species:ncbi:9913">bovine</span>
###xml 347 353 <span type="species:ncbi:9913">bovine</span>
###xml 466 472 <span type="species:ncbi:9913">bovine</span>
###xml 571 577 <span type="species:ncbi:9913">bovine</span>
###xml 675 681 <span type="species:ncbi:9913">bovine</span>
###xml 782 788 <span type="species:ncbi:9913">bovine</span>
DNAse I footprinting followed previously published procedures [24,78] using 33P-end-labeled promoter fragments generated by PCR, KLF15-ZF-GST or GST fusion proteins and EMSA binding buffer optimized for KLF15-ZF. For bovine Rho promoter fragments, the template was a plasmid containing the bovine upstream Rho promoter (-2174 to +32 bp) [36]; for bovine IRBP promoter fragment (-300 to +132 bp), the template was a plasmid containing the corresponding region of the bovine IRBP promoter [30]. Primers used for PCR amplification of promoter fragments were as follows: for bovine Rho (-225 to +70 bp): forward: 5'-AGGCCTCTGCTCTTTCCC-3'; reverse: 5'-CGCCGGCGGCGCGAACCCG-3'; for bovine Rho (-315 to -31 bp): forward: 5'-AGAGGGAAGTGGGCCTAGAG-3', reverse 5'- GAAGTGACCTCCCCTCCCTA-3'; for bovine IRBP: forward: 5'-CAGATGAGACCCCAACATAC-3'; reverse: 5'-ACAGAAGCTCTCTTGACACC-3'. The amount of fusion protein used varied from 16 to 250 ng per reaction and DNAse I digestions were carried out at room temperature for 1 minute.
###end p 45
###begin title 46
Consensus sequence analysis
###end title 46
###begin p 47
###xml 140 142 140 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B66">66</xref>
###xml 415 424 415 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a priori </italic>
To identify consensus sequences for protein binding sites, sequences protected in DNAse I footprinting were analyzed using Target Explorer [66], a program that uses CONSENSUS (version 6c) and WCONSENSUS (version 5c) to determine consensus patterns in unaligned sequences using an algorithm based on a matrix representation of a consensus pattern. WCONSENSUS determines the width of the pattern being sought without a priori knowledge of the length of the consensus sequence.
###end p 47
###begin title 48
Transient transfections
###end title 48
###begin p 49
###xml 141 143 141 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 160 162 160 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 194 196 194 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 244 246 244 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 288 290 288 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 291 293 291 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 64 69 <span type="species:ncbi:9606">human</span>
Promoter transactivation assays used transient transfections of human embryonic kidney cells (293) with expression vectors, hKLF15-pcDNA3.1 [52], Crx-pcDNA3.1 [30], Nrl-pED (gift of A. Swaroop [35]) and luciferase reporter plasmid bRho130-luc [36] following previously published methods [30,52]. The total amount (mug) of DNA in each plate was kept constant by addition of the corresponding expression vector(s) lacking a cDNA insert. Basal activity of each reporter construct in 293 cells was defined as the relative luciferase expression in control plates transfected with reporter constructs and "empty" expression vectors. For each experiment, at least two independent transfections were performed on separate days, and for each combination of expression vectors tested, at least 4 DNA precipitates prepared with each precipitate divided equally to transfect two plates for a total of>/=8 transfections per condition.
###end p 49
###begin title 50
Statistical analyses
###end title 50
###begin p 51
###xml 145 147 145 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
For each condition the fold change in relative luciferase relative to control transfections was calculated and analyzed as previously described [52]. Statistical analysis used linear mixed models and comparisons of bRho130-luc and bRho225-luc reporter constructs used Wilcoxon Two Sample test (SAS; Cary, NC).
###end p 51
###begin title 52
List of abbreviations
###end title 52
###begin p 53
###xml 332 339 332 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Kr&#252;ppel</italic>
###xml 582 589 579 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Kr&#252;ppel</italic>
ATXN7, ataxin-7; BAF, barrier to autointegration factor 1; BTEB3, basic transcription element binding protein 3; Clc-K, kidney-specific chloride channel; CRX, cone-rod homeobox; DTT, dithiothreitol; EDTA, ethylenediaminetraacetic acid; EGTA, O,O'-bis(2-aminoethyl)ethyleneglycol-N,N,N',N'-tetraacetic acid; EKLF, erythroid-specific Kruppel-like factor; ERX, empty spiracles-related homeobox; FIZ-1, Flt3 interacting zinc finger protein 1; GST, glutathione-S-transferase; HEPES, N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid; IPTG, isopropyl-beta-D-thiogalactopyranoside; KLF, Kruppel-like factor; NRL, neural retina leucine zipper; OTX, orthodenticle-related homeobox; QRX, Q50-type retinal homeobox; Rbp3, retinoid binding protein 3; RX/RAX, retina and anterior neural fold homeobox.
###end p 53
###begin title 54
Authors' contributions
###end title 54
###begin p 55
DCO participated in the experimental design, generated and purified fusion proteins, carried out EMSA, DNAse I footprinting, transient transfections, consensus sequence analysis, promoter alignments and drafted the manuscript. HL performed all statistical analyses and contributed to the interpretation of the transfection data; YL isolated the KLF15 clone and contributed to the conceptual basis of the study; DJZ conceived the study, participated in experimental design and data interpretation and helped to draft the manuscript. All authors read and approved the final manuscript.
###end p 55
###begin title 56
Supplementary Material
###end title 56
###begin title 57
Additional File 1
###end title 57
###begin p 58
###xml 362 384 362 384 <bold xmlns:xlink="http://www.w3.org/1999/xlink">KLF15_9bpsite_otteson </bold>
###xml 833 855 833 855 <bold xmlns:xlink="http://www.w3.org/1999/xlink">KLF15: Assume unknown </bold>
###xml 186 192 <span type="species:ncbi:9913">bovine</span>
Supplemental Data Files (Otteson SupplementalData.doc) containing full results of analysis of KFL15 binding sites using Target Explorer. Included in this data set are: 1. Sequences from bovine rhodopsin and IRBP promoters protected by KLF15-gst fusion proteins in DNAseI footprint analysis used as "training set" for Target Explorer. 2. List of top matrices for KLF15_9bpsite_otteson binding site. (sorted by information content): Assume 9 bp binding site and 60% AT/40% GC in genome. 3. Analysis to determine cutoff score for identification of KLF15 binding sites. Sequences and scores for bRho29, hRho29 and bRho29-mutations oligonucleotides used in competitive EMSA. Lists of putative binding sites in these oligos identified using Matrices 1-4: cut-off score = 1 indicating good and poor competitors. 4. List of top matrices for KLF15: Assume unknown binding site length and 60% T/40% GC in genome. 5. Analysis to determine cutoff score for identification of KLF15 binding sites assuming unknown binding site length. Sequences and scores for bRho29, hRho29 and bRho29-mutations oligonucleotides used in competitive EMSA. Lists of putative binding sites in these oligos identified using Matrices 1-4: cut-off score = 1 indicating good and poor competitors. 6. Identification of potential KLF15 binding sites in rhodopsin and IRBP promoters using matrix 2 with 9 bp binding site (cut-off score 4.87). Promoter sequences analyzed. Predicted binding sites
###end p 58
###begin p 59
Click here for file
###end p 59
###begin title 60
Acknowledgements
###end title 60
###begin p 61
Supported in part by grants F32EY13499 (DCO) and EY09769 (DJZ) from the NEI/NIH; the Foundation for Fighting Blindness Foundation and generous gifts from Marshall and Stevie Wishnack, and Robert and Clarice Smith; DJZ is the Guerrieri Professor of Genetic Engineering and Molecular Ophthalmology and is a recipient of the Senior Investigator Award from Research to Prevent Blindness.
###end p 61
###begin article-title 62
###xml 128 132 <span type="species:ncbi:10090">mice</span>
Rhodopsin, 11-cis vitamin A, and interstitial retinol-binding protein (IRBP) during retinal development in normal and rd mutant mice
###end article-title 62
###begin article-title 63
###xml 126 132 <span type="species:ncbi:9913">bovine</span>
Early expression and localization of rhodopsin and interphotoreceptor retinoid-binding protein (IRBP) in the developing fetal bovine retina
###end article-title 63
###begin article-title 64
The immunolocalization and divergent roles of phosducin and phosducin-like protein in the retina
###end article-title 64
###begin article-title 65
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse cone arrestin expression pattern: light induced translocation in cone photoreceptors
###end article-title 65
###begin article-title 66
Developmental expression patterns of phototransduction components in mammalian pineal implies a light sensing function
###end article-title 66
###begin article-title 67
###xml 53 68 <span type="species:ncbi:10090">transgenic mice</span>
Retina-specific expression from the IRBP promoter in transgenic mice is conferred by 212 bp of the 5'-flanking region
###end article-title 67
###begin article-title 68
###xml 89 95 <span type="species:ncbi:9913">bovine</span>
Synthesis and stability of retinal photoreceptor mRNAs are coordinately regulated during bovine fetal development
###end article-title 68
###begin article-title 69
###xml 129 134 <span type="species:ncbi:9606">human</span>
###xml 139 144 <span type="species:ncbi:10090">mouse</span>
Temporal and spatial expression patterns of the CRX transcription factor and its downstream targets. Critical differences during human and mouse eye development
###end article-title 69
###begin article-title 70
###xml 24 27 <span type="species:ncbi:10116">rat</span>
Opsin expression in the rat retina is developmentally regulated by transcriptional activation
###end article-title 70
###begin article-title 71
Transcription of photoreceptor genes during fetal retinal development. Evidence for positive and negative regulation
###end article-title 71
###begin article-title 72
###xml 22 28 <span type="species:ncbi:9913">bovine</span>
###xml 90 95 <span type="species:ncbi:10090">mouse</span>
Unusual topography of bovine rhodopsin promoter-lacZ fusion gene expression in transgenic mouse retinas
###end article-title 72
###begin article-title 73
###xml 37 52 <span type="species:ncbi:10090">transgenic mice</span>
###xml 62 68 <span type="species:ncbi:9913">bovine</span>
Reporter gene expression in cones in transgenic mice carrying bovine rhodopsin promoter/lacZ transgenes
###end article-title 73
###begin article-title 74
###xml 25 30 <span type="species:ncbi:10090">mouse</span>
###xml 107 122 <span type="species:ncbi:10090">transgenic mice</span>
A 221-bp fragment of the mouse opsin promoter directs expression specifically to the rod photoreceptors of transgenic mice
###end article-title 74
###begin article-title 75
A single cis-acting element in a short promoter segment of the gene encoding the interphotoreceptor retinoid-binding protein confers tissue-specific expression
###end article-title 75
###begin article-title 76
###xml 130 133 <span type="species:ncbi:10116">rat</span>
Characterization of developmentally regulated and retina-specific nuclear protein binding to a site in the upstream region of the rat opsin gene
###end article-title 76
###begin article-title 77
###xml 94 97 <span type="species:ncbi:10116">rat</span>
Characterization and regulation of the protein binding to a cis-acting element, RET 1, in the rat opsin promoter
###end article-title 77
###begin article-title 78
###xml 24 31 <span type="species:ncbi:9031">chicken</span>
Characterization of the chicken rhodopsin promoter: identification of retina-specific and glass-like protein binding domains
###end article-title 78
###begin article-title 79
###xml 41 46 <span type="species:ncbi:9606">human</span>
Elements regulating the transcription of human interstitial retinoid-binding protein (IRBP) gene in cultured retinoblastoma cells
###end article-title 79
###begin article-title 80
Functional dissection of the promoter of the interphotoreceptor retinoid-binding protein gene: the cone-rod-homeobox element is essential for photoreceptor-specific expression in vivo
###end article-title 80
###begin article-title 81
###xml 98 103 <span type="species:ncbi:9606">human</span>
Identification of a retina-specific footprint within the retina-specific regulatory region of the human interphotoreceptor retinoid-binding protein gene
###end article-title 81
###begin article-title 82
###xml 50 56 <span type="species:ncbi:9913">bovine</span>
Developmentally important DNA elements within the bovine opsin upstream region
###end article-title 82
###begin article-title 83
###xml 67 72 <span type="species:ncbi:10090">mouse</span>
###xml 77 83 <span type="species:ncbi:9913">bovine</span>
###xml 174 179 <span type="species:ncbi:9031">chick</span>
###xml 198 213 <span type="species:ncbi:10090">transgenic mice</span>
Structural characterization and comparison of promoter activity of mouse and bovine interphotoreceptor retinoid-binding protein (IRBP) gene 5' flanking regions in WERI, Y79, chick retina cells, and transgenic mice
###end article-title 83
###begin article-title 84
###xml 35 38 <span type="species:ncbi:10116">rat</span>
Ret 1, a cis-acting element of the rat opsin promoter, can direct gene expression in rod photoreceptors
###end article-title 84
###begin article-title 85
###xml 73 79 <span type="species:ncbi:9913">bovine</span>
Ret 4, a positive acting rhodopsin regulatory element identified using a bovine retina in vitro transcription system
###end article-title 85
###begin article-title 86
A major cis activator of the IRBP gene contains CRX-binding and Ret-1/PCE-I elements
###end article-title 86
###begin article-title 87
Immediate upstream sequence of arrestin directs rod-specific expression in Xenopus
###end article-title 87
###begin article-title 88
###xml 61 65 <span type="species:ncbi:7962">carp</span>
Retina-specific cis-elements and binding nuclear proteins of carp rhodopsin gene
###end article-title 88
###begin article-title 89
###xml 63 68 <span type="species:ncbi:10090">mouse</span>
Evidence of a tissue-restricting DNA regulatory element in the mouse IRBP promoter
###end article-title 89
###begin article-title 90
Conserved transcriptional activators of the xenopus rhodopsin gene
###end article-title 90
###begin article-title 91
Crx, a novel Otx-like paired-homeodomain protein, binds to and transactivates photoreceptor cell-specific genes
###end article-title 91
###begin article-title 92
Both PCE-1/RX and OTX/CRX interactions are necessary for photoreceptor- specific gene expression
###end article-title 92
###begin article-title 93
Erx, a novel retina-specific homeodomain transcription factor, can interact with Ret 1/PCEI sites
###end article-title 93
###begin article-title 94
QRX, a novel homeobox gene, modulates photoreceptor gene expression
###end article-title 94
###begin article-title 95
OTX2 homeodomain protein binds a DNA element necessary for interphotoreceptor retinoid binding protein gene expression
###end article-title 95
###begin article-title 96
The basic motif-leucine zipper transcription factor Nrl can positively regulate rhodopsin gene expression
###end article-title 96
###begin article-title 97
The bZIP transcriptionfactor Nrl stimulates rhodopsin promoter activity in primary retinal cell cultures
###end article-title 97
###begin article-title 98
Nrl and Sp nuclear proteins mediate transcription of rod-specific cGMP-phosphodiesterase beta-subunit gene: involvement of multiple response elements
###end article-title 98
###begin article-title 99
Functional analysis of the rod photoreceptor cGMP phosphodiesterase alpha-subunit gene promoter: Nrl and Crx are required for full transcriptional activity
###end article-title 99
###begin article-title 100
The leucine zipper of NRL interacts with the CRX homeodomain. A possible mechanism of transcriptional synergy in rhodopsin regulation
###end article-title 100
###begin article-title 101
###xml 66 70 <span type="species:ncbi:10090">mice</span>
Retinopathy and attenuated circadian entrainment in Crx-deficient mice
###end article-title 101
###begin article-title 102
Nrl is required for rod photoreceptor development
###end article-title 102
###begin article-title 103
A range of clinical phenotypes associated with mutations in CRX, a photoreceptor transcription-factor gene
###end article-title 103
###begin article-title 104
Mutations in the cone-rod homeobox gene are associated with the cone-rod dystrophy photoreceptor degeneration
###end article-title 104
###begin article-title 105
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">De novo </italic>
De novo mutations in the CRX homeobox gene associated with Leber congenital amaurosis
###end article-title 105
###begin article-title 106
Retinal degenerations with truncation mutations in the cone-rod homeobox (CRX) gene
###end article-title 106
###begin article-title 107
Positive and negative regulators of neural fate
###end article-title 107
###begin article-title 108
Neurological disease: listening to gene silencers
###end article-title 108
###begin article-title 109
The zinc finger transcription factor, MOK2, negatively modulates expression of the interphotoreceptor retinoid-binding protein gene, IRBP
###end article-title 109
###begin article-title 110
###xml 93 98 <span type="species:ncbi:10090">mouse</span>
Polyglutamine-expanded Ataxin-7 antagonizes CRX function and induces cone-rod dystrophy in a mouse model of SCA7
###end article-title 110
###begin article-title 111
Barrier-to-autointegration factor (Baf) interacts with the cone-rod homeobox (Crx) and represses it transactivation function
###end article-title 111
###begin article-title 112
Interaction of retinal bZIP transcription factor NRL with Flt3-interacting zinc-finger protein Fiz1: possible role of Fiz1 as a transcriptional repressor
###end article-title 112
###begin article-title 113
Kruppel-like factor 15, a zinc-finger transcriptional regulator, represses the rhodopsin and interphotoreceptor retinoid-binding protein promoters
###end article-title 113
###begin article-title 114
Transcriptional regulation of the CLC-K1 promoter by myc-associated zinc finger protein and kidney-enriched Kruppel-like factor, a novel zinc finger repressor
###end article-title 114
###begin article-title 115
The Kruppel-like factor KLF15 regulates the insulin-sensitive glucose transporter GLUT4
###end article-title 115
###begin article-title 116
Sp1 and its likes: biochemical and functional predictions for a growing family of zinc finger transcription factors
###end article-title 116
###begin article-title 117
Sp1- and Kruppel-like transcription factors
###end article-title 117
###begin article-title 118
Erythroid Kruppel-like factor is recruited to the CACCC box in the beta-globin promoter but not to the CACCC box in the gamma-globin promoter: the role of the neighboring promoter elements
###end article-title 118
###begin article-title 119
An erythroid specific nuclear factor binding to the proximal CACCC box of the beta-globin gene promoter
###end article-title 119
###begin article-title 120
Kruppel-like factor 8: a CACCC-box binding protein that associates with CtBP and represses transcription
###end article-title 120
###begin article-title 121
Zinc finger proteins: new insights into structural and functional diversity
###end article-title 121
###begin article-title 122
Metal binding and folding properties of a minimalist Cys2His2 zinc finger peptide
###end article-title 122
###begin article-title 123
Zinc in the retina
###end article-title 123
###begin article-title 124
Zinc and the eye
###end article-title 124
###begin article-title 125
Metalloregulation of the tumor suppressor protein p53: zinc mediates the renaturation of p53 after exposure to metal chelators in vitro and in intact cells
###end article-title 125
###begin article-title 126
Modulation of p53 protein conformation and DNA-binding activity by intracellular chelation of zinc
###end article-title 126
###begin article-title 127
Target Explorer: an automated tool for the identification of new target genes for a specified set of transcription factors
###end article-title 127
###begin article-title 128
DNA recognition by Cys2His2 zinc finger proteins
###end article-title 128
###begin article-title 129
Zinc finger proteins as designer transcription factors
###end article-title 129
###begin article-title 130
The architectural transcription factor high mobility group I(Y) participates in photoreceptor-specific gene expression
###end article-title 130
###begin article-title 131
Evolution of transcription factor binding sites in mammalian gene regulatory regions: conservation and turnover
###end article-title 131
###begin article-title 132
Transcriptional regulation and the evolution of development
###end article-title 132
###begin article-title 133
###xml 53 58 <span type="species:ncbi:10090">mouse</span>
Opsin, G-protein and 48-kDa protein in normal and rd mouse retinas: developmental expression of mRNAs and proteins and light/dark cycling of mRNAs
###end article-title 133
###begin article-title 134
###xml 74 79 <span type="species:ncbi:10090">mouse</span>
Annotation and analysis of 10,000 expressed sequence tags from developing mouse eye and adult retina
###end article-title 134
###begin article-title 135
###xml 111 116 <span type="species:ncbi:10090">mouse</span>
Timing of interphotoreceptor retinoid-binding protein (IRBP) gene expression and hypomethylation in developing mouse retina
###end article-title 135
###begin article-title 136
Site-specific DNA hypomethylation permits expression of the IRBP gene
###end article-title 136
###begin article-title 137
Site-specific acetylation by p300 or CREB binding protein regulates erythroid Kruppel-like factor transcriptional activity via its interaction with the SWI-SNF complex
###end article-title 137
###begin article-title 138
The Sp1-like protein BTEB3 inhibits transcription via the basic transcription element box by interacting with mSin3A and HDAC-1 co-repressors and competing with Sp1
###end article-title 138
###begin article-title 139
Cloning and characterization of retinal transcription factors, using target site-based methodology
###end article-title 139
###begin title 140
Figures and Tables
###end title 140
###begin p 141
###xml 465 467 465 467 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 672 674 672 674 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 794 796 794 796 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 1061 1063 1061 1063 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 529 535 <span type="species:ncbi:9913">bovine</span>
###xml 747 752 <span type="species:ncbi:9606">human</span>
EMSA analysis of KLF15 binding. (A) KLF15-ZF fusion protein. Lanes 1 and 2 show western blots of crude bacterial lysates at 1.5 and 2 hours following induction of fusion protein expression. Anti-GST antibodies detect a major band of the anticipated size and additional lower molecular weight bands. Lane 3, Coomassie stained gel of affinity purified KLF15-ZF-GST fusion protein showing enrichment of major band containing full length fusion protein. (B) EMSA using 32P-labeled oligomers (bRho29) containing a 29 bp fragment from bovine rhodopsin promoter (-94 to -66). Lane 1: no protein; Lane 2: 67.5 ng GST; Lane 3-5: 100, 50, 25 ng KLF15-ZF-GST. (C) Same as (B) except 32P-labeled oligonucleotide (hRho29) contained corresponding sequence from human rhodopsin promoter. (D) Supershift using 32P-bRho29 oligonucleotide and anti-KLF15 antibodies. Lane 1, no protein; Lane 2, 33 ng GST protein; Lane 3, 33 ng GST + anti-KLF15; Lane 4, 50 ng KLF15-ZF-GST protein; Lanes 5-7, 50 ng KLF15-ZF-GST protein plus increasing amounts of anti-KLF15. (E) Supershift using 32P-bRho29 oligonucleotide and anti-GST antibodies. Lane 1, 50 ng KLF15-ZF-GST protein; Lanes 2-4, 50 ng KLF15-ZF-GST protein plus increasing amounts of anti-GST. Large arrows, KLF15 shifted bands; small arrows, non-specific bands; arrowheads, supershifted bands.
###end p 141
###begin p 142
###xml 58 60 58 60 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 245 247 245 247 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 293 294 293 294 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 332 333 332 333 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 128 134 <span type="species:ncbi:9913">bovine</span>
Effects of zinc chelation on KLF15 Binding. A. EMSA using 32P-labeled oligomers (bRho29) containing -96 to -66 bp fragment from bovine rhodopsin promoter. Lane 1, GST protein; Lane 2, KLF15-ZF-GST protein, Lanes 3 -7 same as 2 with EDTA and ZnCl2 (mM) as indicated. B. Same as A, but with MgCl2. C. Same as A, but with EGTA and ZnCl2. The altered migration of the unbound oligonucleotides is attributable to the salt effects of high concentrations of EGTA.
###end p 142
###begin p 143
###xml 27 29 27 29 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 56 62 <span type="species:ncbi:9913">bovine</span>
###xml 410 416 <span type="species:ncbi:9913">bovine</span>
###xml 488 494 <span type="species:ncbi:9913">bovine</span>
Competitive EMSA using (A) 32P- bRho29 oligonuclotides (bovine). Lane 1, no protein; lane 2, GST protein control; lane 3, KLF15-ZF-GST without competitor; lanes 4 -11, same as lane 3 but with unlabeled competitors (50 x, 250 x fold-excess) as indicated. Large arrows indicate specific bands; small arrow indicates non-specific band present in negative (no protein and GST only) controls; IRBP1, MOK2 site from bovine IRBP promoter (5'-GGACAGGATTAAAGGCTTACTGGAG-3'); IRBP2, MOK2 site from bovine IRBP intron1 (5'-GGACTTGTCAGGGCCTTTA-3')
###end p 143
###begin p 144
###xml 73 83 73 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rhodopsin </italic>
###xml 253 255 253 255 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 592 594 592 594 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 66 72 <span type="species:ncbi:9913">bovine</span>
Sequence specificity of KLF15 binding: mutational analysis of the bovine rhodopsin promoter element (bRho29). (A) Sequence of oligomers used in EMSA analysis showing mutations analyzed in B and C. (B) Graph summarizing results of competitive EMSA using 32P-labeled bRho29 and unlabeled mutant oligomers as indicated. B, bRho29 competitor; H, hRho20 competitor. Bars show % of shifted oligonucleotide competed by addition of cold competitor. Bars with negative value reflect an increase in the amount of oligonucleotide shifted following the addition of cold competitor. (C) Same as B, except 32P-labeled hRho29 oligonucleotide was used.
###end p 144
###begin p 145
###xml 164 166 164 166 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 198 200 198 200 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 129 134 <span type="species:ncbi:10090">mouse</span>
Binding of KLF15 site by retinal proteins in EMSA. All lanes contain equal amounts of total retinal extract from wild-type adult mouse retina. Lanes 1, 3, 4 and 5, 32P-labeled bRho29 oligo; lane 2, 32P-labeled Delta10 oligo containing mutated KLF15 binding site; cold Delta10 oligo as competitor was added to lane 4, at 20-fold excess and lane 5, at 200-fold excess. Open arrowheads, bands shifted with both wild-type and mutant oligos; solid arrowheads, bands observed only with wild-type oligos; large and small arrows respectively indicate major and minor bands not competed by addition of excess mutant oligo. Discontinuities in the image resulted from removal of irrelevant lanes.
###end p 145
###begin p 146
###xml 57 67 57 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rhodopsin </italic>
###xml 160 162 160 162 <sup xmlns:xlink="http://www.w3.org/1999/xlink">33</sup>
###xml 965 967 965 967 <sup xmlns:xlink="http://www.w3.org/1999/xlink">33</sup>
###xml 127 133 <span type="species:ncbi:9913">bovine</span>
DNAse I footprint analysis of KLF15 binding sites in the rhodopsin promoter. (A) A PCR fragment spanning -225 to +70 bp of the bovine RPPR was end labeled with 33P at the -225 bp end (forward strand) and incubated with 250, 125, 62.5 and 31.25 ng of purified KLF15-ZF fusion protein (lanes 2-5). Lanes 1 and 6 contained no fusion protein. Protected regions are designated by lines on the left of the image with the nucleotide position of each protected region indicated. Previously identified protein binding sites are indicated by brackets. Solid arrowheads indicate novel hypersensitive sites resulting from KLF15-ZF binding; small arrows indicate hypersensitive sites that are lost or altered by KLF15-ZF binding. Transcription start site (+1) is indicated by an open arrowhead. (B) Same as (A) except the -225 to +70 fragment was labeled at the +70 end (reverse strand). (C) Same as (A) except the PCR fragment used spanned -315 to -31 and was end-labeled with 33P at the -315 end (forward strand) and lanes 1 and 5 contained no protein. (D) Same as (C) except the -315 to -31 fragment was labeled at the -31 end (reverse strand).
###end p 146
###begin p 147
###xml 57 62 57 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IRBP </italic>
###xml 129 134 129 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IRBP </italic>
###xml 164 166 164 166 <sup xmlns:xlink="http://www.w3.org/1999/xlink">33</sup>
###xml 661 663 661 663 <sup xmlns:xlink="http://www.w3.org/1999/xlink">33</sup>
###xml 122 128 <span type="species:ncbi:9913">bovine</span>
DNAse I footprint analysis of KLF15 binding sites in the IRBP promoter. (A) A PCR fragment spanning -132 to +70 bp of the bovine IRBP promoter was end labeled with 33P at the -132 bp end (forward strand) and incubated with 250, 125 and 62.5 ng of purified KLF15-ZF fusion protein (lanes 2-4). Lanes 1 and 5 contained no fusion protein. Protected regions are designated by bars on the left of each panel with the nucleotide position of each protected region indicated. Previously identified protein binding sites are indicated by brackets. Transcription start site (+1) is indicated by an open arrowhead. (B) Same as (A) except the fragment was end-labeled with 33P at the +70 end (reverse strand). The bands present in KI-a (indicated by grey bar in Panel A) were also present in negative control lanes containing undigested probe (data not shown).
###end p 147
###begin p 148
###xml 17 27 17 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rhodopsin </italic>
###xml 223 241 223 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">Additional file: 1</xref>
###xml 85 91 <span type="species:ncbi:9913">bovine</span>
###xml 528 534 <span type="species:ncbi:9913">bovine</span>
###xml 620 626 <span type="species:ncbi:9913">bovine</span>
###xml 631 636 <span type="species:ncbi:9606">Human</span>
###xml 651 654 <span type="species:ncbi:9615">dog</span>
###xml 659 662 <span type="species:ncbi:10116">rat</span>
###xml 667 672 <span type="species:ncbi:10090">mouse</span>
Alignment of (A) rhodopsin and (B) IRBP proximal promoters. KLF15 protected sites in bovine promoter are boxed; 9 bp KLF15 binding sites predicted using Target Explorer Matrix with a cutoff score of 4.86 (Table 1; see also Additional file: 1) are underlined and in bold; at locations where multiple overlapping binding sites were predicted, only the one with the highest score is marked. Previously identified protein binding sites/regulatory elements are indicated by heavy solid bars above sequence. Numbering is based on the bovine promoter sequence and an arrowhead indicates the transcriptional start site (+1). B, bovine; H, Human; C, chimp; D, dog; R, rat; M, mouse.
###end p 148
###begin p 149
###xml 20 30 20 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rhodopsin </italic>
###xml 106 112 <span type="species:ncbi:9913">bovine</span>
Effects of KLF15 on rhodopsin promoter. (A) 293 cells in 22 mm dishes were co-transfected with 2.5 mug of bovine rhodopsin (-130 to +70 bp)-luciferase fusion construct (bRho130-luc) together with the indicated amount (mug) of KLF15 expression vector. Luciferase activity (in relative light units) was corrected for transfection efficiency using beta-GAL internal control. Bars show fold-change in relative luciferase expression compared to control transfections using expression vector lacking cDNA inserts. Error bars, 95% confidence interval. (B) same as (A) except 0.25 mug Crx expression vector was added. (C) Same as (A) except 0.25 mug Nrl expression vector was added. (D) Same as (A) except 0.25 mug Crx and 0.25 mug Nrl were added. Statistical differences from (A) control, (B) Crx alone; (C) Nrl alone; and (D) Crx+Nrl indicated by * p = 0.012, ** p < 0.008, *** p < 0.0001.
###end p 149
###begin p 150
###xml 41 50 41 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rhodopsin</italic>
###xml 55 59 55 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IRBP</italic>
Analysis of KLF15 protected sequences in Rhodopsin and IRBP promoters using Target Explorer: Matrix 2: A. Alignment Matrix; B. Frequency Matrix; C. Scoring Matrix
###end p 150

